Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Due to the benzene content of ca. 50 % and the known effects of benzene on the haematopoitic system, a labeling with STOT RE Cat.1 according to CLP and T, R48/23/24/25 is required.

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Due to the benzene content of ca. 50 % and the known effects of benzene on the haematopoitic system, a labeling with STOT RE Cat.1 according to CLP and T, R48/23/24/25 is required. Based on the available data for other components of the substance, an effect on the ZNS also has to be expected.

Justification for classification or non-classification

Due to the benzene content of ca. 50 % and the known effects of benzene on the haematopoitic system, a labeling with STOT RE Cat.1 according to CLP and T, R48/23/24/25 is required.